Vital Signs

Showing 1-10 of 307

This research service provides an exhaustive overview of vital signs monitoring and the current trends in vital sign monitoring technologies . It discusses the latest technologies that have revolutionized the vital signs monitoring industry as of today, and offers strategic recommendations on expanding the scope and use of vital sign monitors.

USD 4,950.00

USD 3,712.50 save 25 %

08 Dec 2008  |  North America

North American Vital Signs Monitoring Market Outlook

 

This research service analyzes major market trends since 2005, predicts future changes in market measurements through the year 2015, and discusses specific challenges facing industry participants as well as drivers and restraints. It three total markets including the blood pressure monitoring market, the pulse oximetry market, and the temperature m...

USD 4,950.00

USD 3,712.50 save 25 %

01 May 2006  |  North America

Vital Signs - 1 May 2006

 

This issue of Vital Signs, released on May 1, 2006, provides a strategic overview of the possible impact of Medical Tourism on the U.S. Healthcare system and markets. Additionally, a company profile is provided on CoAxia, a company dedicated to the development of next generation technology in the treatment of cerebral ischemia due to stroke or vas...

USD 1,500.00

USD 1,125.00 save 25 %

08 May 2006  |  North America

Vital Signs - 8 May 2006

 

This issue of Vital Signs, released on May 8, 2006, provides a strategic overview of the possible impact of the Massachusetts Health Plan on the uninsured population within the state as well as speculation on the potential national impact a similar plan could have within other states. Additionally, a company profile is provided on Liponex, a bioph...

USD 1,500.00

USD 1,125.00 save 25 %

05 Jun 2006  |  North America

Vital Signs - 5 June 2006

 

This issue of Vital Signs, released on June 5, 2006, provides a strategic overview of the potential impact of Medicare cuts on the oxygen therapy market. Additionally, an emerging company profile is provided on Inogen, a company that is redefining oxygen therapy. Reimbursement and regulatory news from the FDA and CMS are also provided for the wee...

USD 1,500.00

USD 1,125.00 save 25 %

28 Aug 2006  |  North America

Vital Signs - 28 August 2006

 

This issue of Vital Signs, released on August 28, 2006, provides a strategic overview of opportunites for recombinant DNA technologies. Additionally, an emerging company profile is provided for Gerard Biotech, a leader in bringing new technologies to researchers that significantly outperform existing methods. Reimbursement and regulatory news from ...

USD 1,500.00

USD 1,125.00 save 25 %

04 Jun 2007  |  North America

Vital Signs - Competitive Bidding - Chaos and Confusion

 

This issue of Vital Signs, released on June 4, 2007, provides an strategic overview of the state of the industry in the wake of competitive bidding in Medicare. Additionally, a company profile is provided for Genzyme, a leader in biotechnology. Reimbursement and regulatory news from the FDA is also provided for May 21 - May 25, 2007.

USD 1,500.00

USD 1,125.00 save 25 %

15 May 2006  |  North America

Vital Signs - 15 May 2006

 

This issue of Vital Signs, released on May 15, 2006, provides a strategic overview of an industry initiative to reduce the complexity and streamline life sciences information technology. Additionally, an emerging company profile is provided on Teranode, a laboratory informatics software company whose products dramatically shorten deployment cycles...

USD 1,500.00

USD 1,125.00 save 25 %

22 May 2006  |  North America

Vital Signs - 22 May 2006

 

This issue of Vital Signs, released on May 22, 2006, provides a strategic overview of the trickle down effects of budget cuts on biomedical research, potentially hampering the pipeline of innovation. Additionally, an emerging company profile is provided on High Throughput Genomics, Inc, a company dedicated to the development of next generation tec...

USD 1,500.00

USD 1,125.00 save 25 %

12 Jun 2006  |  North America

Vital Signs - 12 June 2006

 

This issue of Vital Signs, released on June 12, 2006, provides a strategic overview of the potential impact of patent expirations of blockbuster drugs and the resulting growth opportunity for generic drugs. Additionally, an emerging company profile is provided on Cell Genesys, a biotechnology company focused on the development and commercializatio...

USD 1,500.00

USD 1,125.00 save 25 %

Showing 1-10 of 307